Skip to main content

TransAct Technologies Announces Participation in Two Upcoming Investor Conferences

TransAct Technologies Incorporated (Nasdaq: TACT), a global leader in software-driven technology and printing solutions for high-growth markets, announced today that Bart Shuldman, Chief Executive Officer, is scheduled to participate in the following upcoming investor conferences:

  • Roth 11th Annual Technology Event – The Company is scheduled to participate in one-on-one meetings on Wednesday, November 16, 2022 at The Yale Club in New York City.
  • 13th Annual Craig-Hallum Alpha Select Conference – The Company is scheduled to participate in one-on-one meetings on Thursday, November 17, 2022 at the Sheraton New York Times Square Hotel in New York City.

About TransAct Technologies Incorporated

TransAct Technologies Incorporated is a global leader in developing and selling software-driven technology and printing solutions for high-growth markets including food service, casino and gaming and POS automation. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the BOHA!™, AccuDate™, EPICENTRAL®, Epic and Ithaca® brands. TransAct has sold over 3.3 million printers and terminals around the world and is committed to providing world-class service, spare parts and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.

BOHA! is a trademark of TRANSACT Technologies Incorporated. ©2022 TRANSACT Technologies Incorporated. All rights reserved.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.